Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
Lysosomal acid lipase deficiency (LAL-D) is still a little recognized genetic disease with significant morbidity and mortality in children and adults. This document provides guidance on when to suspect LAL-D and how to diagnose it. It is recommended to add lysosomal acid lipase deficiency to the lis...
Guardado en:
| Autores principales: | Bay, Luisa, Cañero Velasco, Cristina, Ciocca, Mirta, Cotti, Andrea, Cuarterolo, Miriam, Fainboim, Alejandro, Fassio, Eduardo, Galoppo, Marcela, Piñero, Federico, Rozenfeld, Paula |
|---|---|
| Formato: | Articulo Revision |
| Lenguaje: | Inglés |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/87678 |
| Aporte de: |
Ejemplares similares
-
Enfermedad hepática y dislipemia como manifestación de deficiencia de lipasa acida lisosomal (LAL-D): aspectos clínicos, diagnósticos y nuevo tratamiento : Actualización
por: Bay, Luisa, et al.
Publicado: (2017) -
Efficacy of pentosan polysulfate in <i>in vitro</i> models of lysosomal storage disorders: Fabry and Gaucher Disease
por: Crivaro, Andrea Natalia, et al.
Publicado: (2019) -
Intake of food source of fatty acids and their relationship with the concentration of serum lipoperoxides in adults with dyslipidemia
por: Barlassina, JD, et al.
Publicado: (2019) -
Cirrhosis : a practical guide to management /
Publicado: (2015) -
Dyslipidemia
Publicado: (2012)